Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Current Taxes: 2023-2025

Historic Current Taxes for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Jun 2025 value amounting to $301,391.

  • Zhengye Biotechnology Holding's Current Taxes was N/A to $301,391 in Q2 2025 from the same period last year, while for Jun 2025 it was $301,391, marking a year-over-year change of. This contributed to the annual value of $283,000 for FY2024, which is 12.86% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Current Taxes stood at $301,391 for Q2 2025, which was up 6.50% from $283,000 recorded in Q4 2024.
  • Zhengye Biotechnology Holding's Current Taxes' 5-year high stood at $318,747 during Q4 2023, with a 5-year trough of $283,000 in Q4 2024.
  • For the 3-year period, Zhengye Biotechnology Holding's Current Taxes averaged around $301,046, with its median value being $301,391 (2025).
  • Over the last 5 years, Zhengye Biotechnology Holding's Current Taxes had its largest YoY gain of -11.21% in 2024, and its largest YoY loss of 11.21% in 2024.
  • Zhengye Biotechnology Holding's Current Taxes (MRQ) stood at $318,747 in 2023, then dropped by 11.21% to $283,000 in 2024, then grew by 6.50% to $301,391 in 2025.
  • Its Current Taxes was $301,391 in Q2 2025, compared to $283,000 in Q4 2024 and $318,747 in Q4 2023.